Communicating Antitachycardia Pacing-Enabled Leadless Pacemaker and Subcutaneous Implantable Defibrillator

The subcutaneous implantable-cardioverter defibrillator (S-ICD) and leadless cardiac pacemaker (LCP) were designed to eliminate the need for transvenous leads, and initial studies have shown safety and efficacy for both devices (2-4). The combined LCP and S-ICD therapy that was studied is a proof of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2016-04, Vol.67 (15), p.1865-1866
Hauptverfasser:	Tjong, Fleur V.Y., MD, Brouwer, Tom F., MD, Kooiman, Kirsten M., PA, Smeding, Lonneke, PhD, Koop, Brendan, PhD, Soltis, Brian, MSc, Shuros, Allan, Wilde, Arthur A.M., MD, PhD, Burke, Martin, DO, Knops, Reinoud E., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Cardiac arrhythmia Cardiac Pacing, Artificial - methods Cardiology Cardiovascular Communication Defibrillators Defibrillators, Implantable Disease Models, Animal Electric Countershock - instrumentation Electric Countershock - methods Internal Medicine Pacemaker, Artificial Sheep Tachycardia - therapy Treatment Outcome Wireless Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The subcutaneous implantable-cardioverter defibrillator (S-ICD) and leadless cardiac pacemaker (LCP) were designed to eliminate the need for transvenous leads, and initial studies have shown safety and efficacy for both devices (2-4). The combined LCP and S-ICD therapy that was studied is a proof of concept of successful wireless device-device communication in cardiac rhythm management and a first step toward establishing multicomponent device systems that eliminate transvenous leads.
ISSN:	0735-1097 1558-3597
DOI:	10.1016/j.jacc.2016.02.039